Robert Roger Lebel, MD, professor and chief of medical genetics at Upstate Medical University, will describe a genetic disorder called the chromosome 22q deletion, also known as velo-cardio-facial syndrome (VCFS). The syndrome may cause a variety of health problems, ranging from heart defects and cleft palate to feeding difficulties, immune problems, a unique pattern of learning disabilities and more.
Mantosh Dewan, MD, distinguished service professor of psychiatry and behavioral sciences at Upstate, is joined by Christopher Morley, PhD, associate professor of family medicine, public health, and psychiatry, and vice-chair for research in the Department of Family Medicine, will help us understand the genetics of psychiatric illnesses like schizophrenia. Upstate is involved in the largest-ever case-control study of schizophrenia, and is actively seeking to recruit about 200 more healthy/unaffected subjects in the next few months. For more information, call 315-464-6943 or email firstname.lastname@example.org.
A more precise technique to determine non-reimbursed costs of preauthorizations – also referred to as prior authorizations – to physician practices has been used in a study by researchers from the Department of Family Medicine at Upstate Medical University. Christopher Morley, PhD, vice-chair for research in Family Medicine, will join us to talk about their findings.
Rosemary Rochford PhD is widely known for her research on Burkitt’s Lymphoma, the most common childhood cancer in sub-Saharan Africa. She will talk about the cancer challenges in developing countries, how the cancer registry programs work, the main types of cancers that exist in Africa and how they differ from those in the United States. Rochford is professor & chair of Microbiology & Immunology and recently appointed vice president for research at Upstate.
Rosemary Rochford PhD: Challenges in Cancer Research in Africa[ 0.01 MB ]Play Now | Download
Upstate hematologist/oncologist Ajeet Gajra will talk about the theory behind ‘personalized cancer care’ – how it differs from ‘targeted therapy’, and how the Upstate Cancer Center provides this type of care. Upstate is involved in a variety of active trials seeking participants.